Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3DU8

Crystal structure of GSK-3 beta in complex with NMS-869553A

Summary for 3DU8
Entry DOI10.2210/pdb3du8/pdb
DescriptorGlycogen synthase kinase-3 beta, (7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one (3 entities in total)
Functional Keywordsprotein kinase, alternative splicing, atp-binding, nucleotide-binding, phosphoprotein, serine/threonine-protein kinase, transferase
Biological sourceHomo sapiens
Cellular locationCytoplasm : P49841
Total number of polymer chains2
Total formula weight94461.33
Authors
Bossi, R.T. (deposition date: 2008-07-17, release date: 2009-03-03, Last modification date: 2023-08-30)
Primary citationMenichincheri, M.,Bargiotti, A.,Berthelsen, J.,Bertrand, J.A.,Bossi, R.,Ciavolella, A.,Cirla, A.,Cristiani, C.,Croci, V.,D'Alessio, R.,Fasolini, M.,Fiorentini, F.,Forte, B.,Isacchi, A.,Martina, K.,Molinari, A.,Montagnoli, A.,Orsini, P.,Orzi, F.,Pesenti, E.,Pezzetta, D.,Pillan, A.,Poggesi, I.,Roletto, F.,Scolaro, A.,Tato, M.,Tibolla, M.,Valsasina, B.,Varasi, M.,Volpi, D.,Santocanale, C.,Vanotti, E.
First Cdc7 kinase inhibitors: pyrrolopyridinones as potent and orally active antitumor agents. 2. Lead discovery.
J.Med.Chem., 52:293-307, 2009
Cited by
PubMed Abstract: Cdc7 kinase is a key regulator of the S-phase of the cell cycle, known to promote the activation of DNA replication origins in eukaryotic organisms. Cdc7 inhibition can cause tumor-cell death in a p53-independent manner, supporting the rationale for developing Cdc7 inhibitors for the treatment of cancer. In this paper, we conclude the structure-activity relationships study of the 2-heteroaryl-pyrrolopyridinone class of compounds that display potent inhibitory activity against Cdc7 kinase. Furthermore, we also describe the discovery of 89S, [(S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoro-ethyl)-1,5,6,7-tetrahydropyrrolo[3,2-c]pyridin-4-one], as a potent ATP mimetic inhibitor of Cdc7. Compound 89S has a Ki value of 0.5 nM, inhibits cell proliferation of different tumor cell lines with an IC50 in the submicromolar range, and exhibits in vivo tumor growth inhibition of 68% in the A2780 xenograft model.
PubMed: 19115845
DOI: 10.1021/jm800977q
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.2 Å)
Structure validation

238268

数据于2025-07-02公开中

PDB statisticsPDBj update infoContact PDBjnumon